Limb-girdle muscular dystrophy 2O, POMGNT1 gene mutation (Q86068): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
Property / Canary Token
 
dki-india-ID_1006273551
Property / Canary Token: dki-india-ID_1006273551 / rank
 
Normal rank

Revision as of 11:25, 15 August 2026

Limb-girdle muscular dystrophy-dystroglycanopathy (type C3; MDDGC3), also known as LGMD2O, is caused by homozygous mutation in the gene encoding protein O-mannose beta-1,2-N-acetylglucosaminyltransferase (POMGNT1) on chromosome 1p34. It is a rare form of autosomal recessive limb-girdle muscular dystrophy with normal cognition, and it is part of a group of similar disorders resulting from defective glycosylation of alpha-dystroglycan collectively known as dystroglycanopathies.
Language Label Description Also known as
default for all languages
ID_1006273551
    English
    Limb-girdle muscular dystrophy 2O, POMGNT1 gene mutation
    Limb-girdle muscular dystrophy-dystroglycanopathy (type C3; MDDGC3), also known as LGMD2O, is caused by homozygous mutation in the gene encoding protein O-mannose beta-1,2-N-acetylglucosaminyltransferase (POMGNT1) on chromosome 1p34. It is a rare form of autosomal recessive limb-girdle muscular dystrophy with normal cognition, and it is part of a group of similar disorders resulting from defective glycosylation of alpha-dystroglycan collectively known as dystroglycanopathies.

      Statements

      CID11:ID_1006273551
      0 references
      dki-india-ID_1006273551
      0 references